Invitrogen Announces Opening of Hepatocyte Supply Facility in Warrington, UK
News Dec 03, 2009
Invitrogen has announced the opening of a new facility in Warrington, UK, which will supply freshly isolated human hepatocytes to researchers in Europe.
Human hepatocytes isolated from liver tissue are used for many biopharmaceutical applications, by researchers investigating liver diseases, and by scientists in the biotech and pharmaceutical sectors trying to predict a compound’s effect on enzyme metabolism in the liver. Many of these kinds of investigations are recommended by the US Food and Drug Administration (FDA) to minimize costly failures during clinical trials.
The new facility in Warrington will supplement the existing facility in North Carolina, USA, and will focus on the regular supply of fresh human hepatocytes to researchers in Europe. Fresh hepatocytes have a short shelf life, but they maintain key functions important for monitoring drug metabolism in vitro. A Rapid Alert™ email notification system has been developed in order to notify researchers of the availability of fresh cells.
“Hepatocytes are a well-established and high growth area of the global primary cells market. The opening of the new facility in Warrington will significantly support this rapidly growing area of hepatic biology in Europe.” said Nicolas Barthelemy, President, Life Technologies’ Cell Systems Division.
“Our new facility is part of Life Technologies ongoing commitment to serving the needs of cell biologists in Europe. The Warrington site will help us to ensure rapid access to high quality hepatocytes, for researchers investigating liver function and compound metabolism across a range of market sectors.” said Rob Brainin, Vice-President and General Manager, Invitrogen Hepatic Biology (CellzDirect) at Life Technologies.
Switch Discovered to Convert Blood Vessels to Blood Stem Cells During Embryonic DevelopmentNews
Findings could aid research into creating new blood cells for transplants and understanding cancer metastasis.READ MORE
Exposure to Low Levels of BPA during Pregnancy Can Lead to Altered Brain DevelopmentNews
New research in mice provides an explanation for how exposure to the widely used chemical bisphenol A (BPA) during pregnancy, even at levels lower than the regulated “safe” human exposure level, can lead to altered brain development and behavior later in life.READ MORE
Moving Toward a Future Free of Drug-Induced Hearing LossNews
A new special publication orchestrated by five of the nation's leading hearing experts compiles the latest research into hearing loss caused by drugs and solvents - how it occurs, how to treat it, and how to prevent it.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018